275
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Effect of Two β-Adrenergic Agonists on Finishing Performance and Carcass Characteristics in Lambs Fed All-Concentrate Diets

, , , , , & show all
Pages 33-36 | Received 11 Sep 2008, Accepted 04 Feb 2009, Published online: 14 Nov 2011
 

Abstract

Robles-Estrada, J.C, Barreras-Serrano, A., Contreras, G., Estrada-Angulo, A., Obregon, J.F., Plascencia, A. and Rios, F.G. 2009. Effect of two p-adrenergic agonists on finishing performance and carcass characteristics in lambs fed all-concentrate diets. J. Appl. Anim. Res., 36: 33–36.

To assess the effect of feeding two (β-adernergic agonists [β-AA, type β1: 20 ppm ractopamine hydochloride (RAC), type β2: 6 ppm zilpaterol hydrochloride (ZIL)] on performance, 60 Pelibuey × Katahdin (34.4 ±2.94 kg) crossbred male lambs were used in a 32-d feeding trial. DM intake was not affected by treatments. Compared with controls, average daily gain and feed efficiency were improved with RAC supplementation, but final live weight, average daily gain and gain: feed were the best on ZIL supplemented group. No differences in carcass characteristics were detected among control group and RAC supplementation. It is concluded that β-AA supplementation increase growth performance in lambs as results of greater muscle accretion and for reduction of body fat. Use as feed additive, β2-AA compound has a greater response in feedlot lambs than β1-AA compound.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.